Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free Anesthesia in Radical Prostatectomy
NCT03212456Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Jan 2017
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in prostate cancer (PCa), sponsored by Instituto do Câncer do Estado de São Paulo. Primary endpoint: Biochemical recurrence of prostate cancer up to 2 years. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03212456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212456.